1.
Dermatol Online J
; 28(4)2022 Aug 15.
Article
in English
| MEDLINE
| ID: mdl-36259862
ABSTRACT
The rapid development and implementation of COVID-19 vaccines throughout the global population has given rise to unique, rare, adverse skin reactions. This case report describes an elderly man with new-onset bullous pemphigoid following the second dose of the Pfizer-BioNTech (mRNA) COVID-19 vaccine.
Subject(s)
COVID-19 Vaccines , COVID-19 , Exanthema , Pemphigoid, Bullous , Aged , Humans , Male , COVID-19 Vaccines/adverse effects , Pemphigoid, Bullous/etiology , RNA, Messenger , Vaccination/adverse effects
2.
Dermatol Surg
; 48(4): 465-466, 2022 04 01.
Article
in English
| MEDLINE
| ID: mdl-35125440
